138
Participants
Start Date
August 31, 2000
Primary Completion Date
July 31, 2006
Study Completion Date
July 31, 2006
Partial schedule of pharmacotherapeutic reinforcement
Dose of 0.1% of Aristocort A on 1-2 of every 4 days for a period of up to 14 weeks.
Dose control for Arm B
Dose of 0.025-0.05% of Aristocort A 2 times per day for a period of up to 14 weeks.
Standard pharmacotherapeutic protocol
Full dose of Aristicort A (0.1%) 2 times per day for a period of up to 14 weeks.
Adult Dermatology Clinic, Strong Memorial Hospital, Rochester
Stanford University, Palo Alto
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Rochester
OTHER